ID

23842

Beschrijving

Study part: Exploratory Biomarker Research Week 38 / Early Withdrawal visit.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Trefwoorden

  1. 15-07-17 15-07-17 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

15 juli 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Exploratory Biomarker Research Week 38 Mepolizumab HES NCT00086658

Exploratory Biomarker Research Week 38

EXPLORATORY BIOMARKER RESEARCH
Beschrijving

EXPLORATORY BIOMARKER RESEARCH

Alias
UMLS CUI-1
C0005516
Has the subject provided written consent for exploratory biomarker research?
Beschrijving

informed consent biomarker

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0005516
Date of Assessment
Beschrijving

Date of Assessment

Datatype

date

Alias
UMLS CUI [1]
C2985720
Date of Assessment Skin Biopsy
Beschrijving

Date of Assessment Skin Biopsy

Datatype

date

Alias
UMLS CUI [1,1]
C2985720
UMLS CUI [1,2]
C0150866
Date of Assessment GI Biopsy
Beschrijving

Date of Assessment GI Biopsy

Datatype

date

Alias
UMLS CUI [1,1]
C2985720
UMLS CUI [1,2]
C0005558
UMLS CUI [1,3]
C0017189

Similar models

Exploratory Biomarker Research Week 38

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
EXPLORATORY BIOMARKER RESEARCH
C0005516 (UMLS CUI-1)
informed consent biomarker
Item
Has the subject provided written consent for exploratory biomarker research?
boolean
C0021430 (UMLS CUI [1,1])
C0005516 (UMLS CUI [1,2])
Date of Assessment
Item
Date of Assessment
date
C2985720 (UMLS CUI [1])
Date of Assessment Skin Biopsy
Item
Date of Assessment Skin Biopsy
date
C2985720 (UMLS CUI [1,1])
C0150866 (UMLS CUI [1,2])
Date of Assessment GI Biopsy
Item
Date of Assessment GI Biopsy
date
C2985720 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0017189 (UMLS CUI [1,3])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial